挖掘和分析与aducanumab相关的不良事件:使用FDA不良事件报告系统数据库的现实研究
Shuangshuang Wu1,2, Yiming Qi1,2, Cheng Jiang1
1Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Expert opinion on drug safety
|December 27, 2024
概括
这项研究使用FAERS数据分析了aducanumab不良事件 (AE),确定了六个新的安全信号. 神经系统疾病,特别是ARIA-E和ARIA-H,在121-240天内在欧洲患者中更为频繁.
科学领域:
- 神经科学是一个神经科学.
- 药物监督 药物监督 药物监督
- 临床研究 临床研究
背景情况:
- 单克隆抗体阿杜卡努马布于2021年被批准用于阿尔茨海默病.
- 对于阿杜卡努马布的安全性概况存在担忧.
- 本研究调查了与aducanumab相关的不良事件 (AE).
研究的目的:
- 使用现实世界的数据来评估与aducanumab相关的不良事件 (AE).
- 确定阿杜卡努马布的潜在新安全信号.
- 分析影响阿杜卡努马布副作用的人口和临床因素.
主要方法:
- 在FDA不良事件报告系统 (FAERS) 数据库中进行数据挖掘.
- 提取阿杜卡努马布-主要的疑似药物报告.
- 分析使用四种不成比例的方法来检测AE信号.
- 根据性别,年龄,体重,剂量,发病时间和大陆对AE的调查.
主要成果:
- 确定了328份报告和793份与阿杜卡努马布相关的副作用.
- 对于aducanumab,检测到六个新的AE信号.
- 神经系统疾病,特别是与粉样蛋白相关的成像异常 (ARIA-E和ARIA-H),在121-240天内报告增加,特别是在欧洲.
- 根据性别或体重,没有观察到AE信号的显著差异.
结论:
- 这项研究提供了关于阿杜卡努马布安全性的真实证据.
- 已识别的AE信号需要进一步调查.
- 了解AE的人口和时间模式可以为临床实践提供信息.
相关概念视频
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342